314 related articles for article (PubMed ID: 31955497)
1. Prostate cancer in kidney transplant recipients - a nationwide register study.
Bratt O; Drevin L; Prütz KG; Carlsson S; Wennberg L; Stattin P
BJU Int; 2020 May; 125(5):679-685. PubMed ID: 31955497
[TBL] [Abstract][Full Text] [Related]
2. Prostate Cancer Outcomes Following Solid-Organ Transplantation: A SEER-Medicare Analysis.
Liauw SL; Ham SA; Das LC; Rudra S; Packiam VT; Koshy M; Weichselbaum RR; Becker YT; Bodzin AS; Eggener SE
J Natl Cancer Inst; 2020 Aug; 112(8):847-854. PubMed ID: 31728517
[TBL] [Abstract][Full Text] [Related]
3. Association Between Pretransplant Cancer and Survival in Kidney Transplant Recipients.
Dahle DO; Grotmol T; Leivestad T; Hartmann A; Midtvedt K; Reisæter AV; Mjøen G; Pihlstrøm HK; Næss H; Holdaas H
Transplantation; 2017 Oct; 101(10):2599-2605. PubMed ID: 28207636
[TBL] [Abstract][Full Text] [Related]
4. Incidence, Management, and Clinical Outcomes of Prostate Cancer in Kidney Transplant Recipients.
Haroon UH; Davis NF; Mohan P; Little DM; Smyth G; Forde JC; Power RE
Exp Clin Transplant; 2019 Jun; 17(3):298-303. PubMed ID: 30602361
[TBL] [Abstract][Full Text] [Related]
5. Bladder cancer in renal allograft recipients: risk factors and outcomes.
Medani S; O'Kelly P; O'Brien KM; Mohan P; Magee C; Conlon P
Transplant Proc; 2014 Dec; 46(10):3466-73. PubMed ID: 25498074
[TBL] [Abstract][Full Text] [Related]
6. Cancer risk and mortality after kidney transplantation: a population-based study on differences between Danish centres using standard immunosuppression with and without glucocorticoids.
Engberg H; Wehberg S; Bistrup C; Heaf J; Sørensen SS; Thiesson HC; Hansen JM; Svensson M; Green A; Marckmann P
Nephrol Dial Transplant; 2016 Dec; 31(12):2149-2156. PubMed ID: 27587604
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis and treatment of prostate cancers in renal-transplant recipients.
Cormier L; Lechevallier E; Barrou B; Benoit G; Bensadoun H; Boudjema K; Descottes JL; Doré B; Guy L; Malavaud B; Martin X; Patard JJ; Petit J; Salomon L
Transplantation; 2003 Jan; 75(2):237-9. PubMed ID: 12548131
[TBL] [Abstract][Full Text] [Related]
8. Effects of prostate-specific antigen testing on familial prostate cancer risk estimates.
Bratt O; Garmo H; Adolfsson J; Bill-Axelson A; Holmberg L; Lambe M; Stattin P
J Natl Cancer Inst; 2010 Sep; 102(17):1336-43. PubMed ID: 20724726
[TBL] [Abstract][Full Text] [Related]
9. Induction Therapy, Rejection, and Graft Outcomes in Pediatric and Adolescent Kidney Transplant Recipients.
Mincham CM; Wong G; Teixeira-Pinto A; Kennedy S; Alexander S; Larkins N; Lim WH
Transplantation; 2017 Sep; 101(9):2146-2151. PubMed ID: 28832451
[TBL] [Abstract][Full Text] [Related]
10. Steroid avoidance or withdrawal for pancreas and pancreas with kidney transplant recipients.
Montero N; Webster AC; Royuela A; Zamora J; Crespo Barrio M; Pascual J
Cochrane Database Syst Rev; 2014 Sep; (9):CD007669. PubMed ID: 25220222
[TBL] [Abstract][Full Text] [Related]
11. Analysis of a single-center experience with mycophenolate mofetil based immunosuppression in renal transplantation.
Triemer HL; Pearson TC; Odom KL; Larsen CP
Clin Transplant; 2000 Aug; 14(4 Pt 2):413-20. PubMed ID: 10946781
[TBL] [Abstract][Full Text] [Related]
12. Outcomes following renal transplantation in older renal transplant recipients: a single-center experience and "Croatian senior program".
Mikolasevic I; Racki S; Spanjol J; Zupan Z; Jakopcic I; Devcic B; Orlic L
Int Urol Nephrol; 2015 Aug; 47(8):1415-22. PubMed ID: 26116149
[TBL] [Abstract][Full Text] [Related]
13. PCBaSe Sweden: a register-based resource for prostate cancer research.
Hagel E; Garmo H; Bill-Axelson A; Bratt O; Johansson JE; Adolfsson J; Lambe M; Stattin P
Scand J Urol Nephrol; 2009; 43(5):342-9. PubMed ID: 19921977
[TBL] [Abstract][Full Text] [Related]
14. Suicide risk in men with prostate-specific antigen-detected early prostate cancer: a nationwide population-based cohort study from PCBaSe Sweden.
Bill-Axelson A; Garmo H; Lambe M; Bratt O; Adolfsson J; Nyberg U; Steineck G; Stattin P
Eur Urol; 2010 Mar; 57(3):390-5. PubMed ID: 19914773
[TBL] [Abstract][Full Text] [Related]
15. Management of Localised Prostate Cancer in Kidney Transplant Patients: A Systematic Review from the EAU Guidelines on Renal Transplantation Panel.
Hevia V; Boissier R; Rodríguez-Faba Ó; Fraser-Taylor C; Hassan-Zakri R; Lledo E; Regele H; Buddde K; Figueiredo A; Olsburgh J; Breda A
Eur Urol Focus; 2018 Mar; 4(2):153-162. PubMed ID: 29921544
[TBL] [Abstract][Full Text] [Related]
16. Evaluation and Active Treatment versus Active Surveillance of Localized Prostate Cancer in Renal Transplant Patients in the Era of Low and Very Low Risk Prostate Cancer.
Aminsharifi A; Simon R; Polascik TJ; Robertson CN; Sudan DL; Collins BH; Moul JW
J Urol; 2019 Sep; 202(3):469-474. PubMed ID: 30835631
[TBL] [Abstract][Full Text] [Related]
17. Immunosuppression and other risk factors for lip cancer after kidney transplantation.
van Leeuwen MT; Grulich AE; McDonald SP; McCredie MR; Amin J; Stewart JH; Webster AC; Chapman JR; Vajdic CM
Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):561-9. PubMed ID: 19190169
[TBL] [Abstract][Full Text] [Related]
18. Low-risk Prostate Cancer Prior to or After Kidney Transplantation.
Stöckle M; Junker K; Fornara P
Eur Urol Focus; 2018 Mar; 4(2):148-152. PubMed ID: 30005996
[TBL] [Abstract][Full Text] [Related]
19. Tacrolimus versus cyclosporin as primary immunosuppression for lung transplant recipients.
Penninga L; Penninga EI; Møller CH; Iversen M; Steinbrüchel DA; Gluud C
Cochrane Database Syst Rev; 2013 May; (5):CD008817. PubMed ID: 23728681
[TBL] [Abstract][Full Text] [Related]
20. Over-diagnosed prostate cancer in solid organ recipients: lessons from the last 3 decades.
Waeckel T; Ait Said K; Altieri M; Belin A; Doerfler A; Tillou X
Int Urol Nephrol; 2021 Feb; 53(2):241-248. PubMed ID: 32926314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]